Company Filing History:
Years Active: 1991-2022
Title: Innovations of Jeremy W Thorner
Introduction
Jeremy W Thorner is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of genomic editing and enzyme production. With a total of 2 patents, his work has advanced the understanding and application of genetic modifications.
Latest Patents
Thorner's latest patents include "Methods and compositions for genomic editing." This patent provides genetically modified cells and non-human organisms, along with methods for producing such entities. The disclosure details how these cells and organisms are genetically modified to include an integrated heterologous nucleic acid, which contains a CRISPR/Cas target sequence. This innovation allows for simultaneous gene editing at multiple positions within a genome using a single species of CRISPR/Cas guide RNA. Another notable patent is "Yeast endopeptidase for basic amino-acid site cleavage, preparation and." This patent outlines methods for endopeptidase production, enhancing processing efficiencies both in vivo and in vitro. The endopeptidase is specific for dibasic amino acid sites, cleaving at the C-side of the dipeptide.
Career Highlights
Throughout his career, Thorner has worked with esteemed organizations such as the University of California and Chiron Corporation. His work in these institutions has contributed to his reputation as a leading figure in his field.
Collaborations
Some of Thorner's notable coworkers include Anthony J Brake and Lindley Blair. Their collaborative efforts have furthered advancements in the areas of genetic research and enzyme technology.
Conclusion
Jeremy W Thorner's innovative work in genomic editing and enzyme production has made a lasting impact on the scientific community. His patents reflect a commitment to advancing technology in genetics, showcasing his role as a key inventor in this vital field.